Page History
Variable Name | Variable Label | Type | Codelist/Controlled Terms | Core | CDISC Notes | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
STUDYID | Study Identifier | Char | Req | LB.STUDYID | ||||||||||||||||||||||||||||
USUBJID | Unique Subject Identifier | Char | Req | LB.USUBJID | ||||||||||||||||||||||||||||
TRTP | Planned Treatment | Char | Cond | ADSL.TRT01P | ||||||||||||||||||||||||||||
TRT01P | Planned Treatment for Period 01 | Char | Cond | ADSL.TRT01P | ||||||||||||||||||||||||||||
TRTA | Actual Treatment | Char | Cond | ADSL.TRT01A | ||||||||||||||||||||||||||||
TRTx01A | Actual Treatment for Period 01 | Char | Cond | ADSL.TRT01A | ||||||||||||||||||||||||||||
ADT | Analysis Date | Num | Perm | LB.LBDTC captured in numeric format | ||||||||||||||||||||||||||||
ADY | Analysis Relative Day | Num | Perm | LB.LBDY | ||||||||||||||||||||||||||||
AVISIT | Analysis Visit | Char | Cond | LB.VISIT | ||||||||||||||||||||||||||||
AVISITN | Analysis Visit (N) | Num | Perm | LB.VISITNUM | ||||||||||||||||||||||||||||
PARAM | Parameter | Char | Req | LB.LBTEST concatenated with LB.LBSTRESU - if PARCAT1=URINALYSIS then preface with Urine | ||||||||||||||||||||||||||||
PARAMCD | Parameter Code | text | Req | LB.LBTESTCD - if PARCAT1=URINALYSIS then preface with U | ||||||||||||||||||||||||||||
PARAMN | Parameter (N) | Num | Perm | Numeric representation of PARAM. Sort by PARCAT! and PARAMCD and increment by 1 for each new LBTESTCD | ||||||||||||||||||||||||||||
PARCAT1 | Parameter Category 1 | Char | Perm | LB.LBCAT | ||||||||||||||||||||||||||||
AVAL | Analysis Value | Num | Cond | LB.LBSTRESN | ||||||||||||||||||||||||||||
AVALC | Analysis Value (C) | Char | Cond | LB.LBSTRESC where LB.LBSTRESN is null | ||||||||||||||||||||||||||||
BASE | Baseline Value | Num | Cond | AVAL where ABLFL=Y | ||||||||||||||||||||||||||||
CHG | Change from Baseline | Num | Perm | AVAL-BASE - populated on ABLFL=Y records and post-baseline records | ||||||||||||||||||||||||||||
PCHG | Percent Change from Baseline | Num | Perm | derived as ((AVAL-BASE)/BASE)*100 | ||||||||||||||||||||||||||||
ABLFL | Baseline Record Flag | Char | Y | Cond | set to Y for last pre-treatment value within each PARAM | |||||||||||||||||||||||||||
ANL01FL | Analysis Flag 01 | Char | Y | Cond | set to Y for last value within PARAM and AVISIT | |||||||||||||||||||||||||||
RANDFL | Randomized | COUNTRY | Country | Char | Perm | ADSL.COUNTRY | AGE | Age | Num | Perm | ADSL.AGE | SEX | Sex | Char | Perm | ADSL.SEX | RACE | Race | Char | Perm | ADSL.RACE | ETHNIC | Ethnicity | Char | Perm | ADSL.ETHNIC | SAFFL | Safety Population Flag | Char | Y;N | Cond | ADSL.RANDFL |
SAFFL | RANDFL | Randomized Safety Population Flag | Char | Y;N | Cond | ADSL.RANDFLSAFFL | ||||||||||||||||||||||||||
TRTSDT | Date of First Exposure to Treatment | Num | Perm | ADSL.TRTSDT | ||||||||||||||||||||||||||||
TRTEDT | Date of Last Exposure to Treatment | Num | Perm | ADSL.TRTEDT | ||||||||||||||||||||||||||||
LBSEQ | Sequence Number | Num | Perm | LB.LBSEQ | ||||||||||||||||||||||||||||
VISITNUM | Visit Number | Num | Perm | LB.VISITNUM | ||||||||||||||||||||||||||||
LBDTC | Date/Time of Specimen Collection | Char | Perm | LB.LBDTC |
STUDYID | USUBJID | TRTP | TRT01P | TRTA | TRT01A | ADT | ADY | AVISIT | AVISITNLBSEQ | PARAM | PARAMCD | PARAMN | PARCAT1 | AVAL | AVALC | BASE | CHG | PCHG | ABLFL | ANL01FL | LBSTNRC | ANRLO | ANRHI | ANRIND | LBLOINC | LBSPEC | RANDFL | SAFFLABLFL | LBCLSIG | LBSEQ | VISITNUM | LBDTC | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A123 | A2001 | Product A | Product A | Product A | Product A | 02JAN2021 | -6 | SCREENING1 | 1 | Leukocytes (10^9/L) | WBC | 6 | HEMATOLOGY | 11.0 | 11.0 | Y | Y | 4.5 | 11.0 | 26464-8 | BLOOD | Y | Y | 1 | 1 | 2021-01-02 | ||||||||
A123 | 001-001 | Product A | Product A | Product A | Product A | 02JAN2021 | -6 | SCREENING | 1 | 2 | RBC (10^12/L) | RBC | 8 | HEMATOLOGY | 5.4 | 5.4 | Y | Y | 4.7 | 6.1 | 33051-4 | BLOOD | Y | Y | 2 | 1 | 2021-01-02 | |||||||
A123 | A2001 | Product A | Product A | Product A | Product A | 02JAN2021 | -6 | SCREENING | 13 | Platelets (10^9/L) | PLAT | 7 | HEMATOLOGY | 158 | 158 | Y | Y | 150 | 400 | 49497-1 | BLOOD | Y | Y | 3 | 1 | 2021-01-02 | ||||||||
A123 | A2001 | Product A | Product A | Product A | Product A | 02JAN2021 | -6 | SCREENING | 1 | 4 | Hemoglobin (g/dL) | HGB | 5 | HEMATOLOGY | 14.5 | 14.5 | Y | Y | 14 | 18 | 718-7 | BLOOD | Y | Y | 4 | 1 | 2021-01-02 | |||||||
A123 | A2001 | Product A | Product A | Product A | Product A | 02JAN2021 | -6 | SCREENING | 15 | Cholesterol (mg/dL) | CHOL | 2 | CLINICAL CHEMISTRY | 229 | 229 | Y | Y | 200 | 2093-3 | BLOOD | Y | Y | 5 | 1 | 2021-01-02 | |||||||||
A123 | A2001 | Product A | Product A | Product A | Product A | 02JAN2021 | -6 | SCREENING | 16 | Albumin (g/L) | ALB | 1 | CLINICAL CHEMISTRY | 4.0 | 4.0 | Y | Y | 3.4 | 5.4 | 2862-1 | BLOOD | Y | Y | 6 | 1 | 2021-01-02 | ||||||||
A123 | A2001 | Product A | Product A | Product A | Product A | 02JAN2021 | -6 | SCREENING | 17 | Creatinine (mg/dL) | CREAT | 3 | CLINICAL CHEMISTRY | 0.8 | 0.8 | Y | Y | 0.7 | 1.3 | 2160-0 | BLOOD | Y | Y | 7 | 1 | 2021-01-02 | ||||||||
A123 | A2001 | Product A | Product A | Product A | Product A | 02JAN2021 | -6 | SCREENING | 18 | Urine Specific Gravity | USPGRAV | 9 | URINALYSIS | Y | Y | 1.005 | 1.030 | 2965-2 | URINE | Y | Y | 8 | 1 | 2021-01-02 | ||||||||||
A123 | A2001 | Product A | Product A | Product A | Product A | 02JAN2021 | -6 | SCREENING | 1 | 9 | Cannabinoids | CANNAB | 4 | DRUG TOXICITY | POSITIVE | NEGATIVE | ABNORMAL | 18282-4 | URINE | Y | Y | Y | 9 | 1 | 2021-01-02 |
Overview
Content Tools